SRE Form 4: Kevin Sagara Disposes 14,433 Shares Under Pre-Set Plan

Rhea-AI Filing Summary

Kevin C. Sagara, a director of Sempra (SRE), reported the sale of 14,433 shares of the company's common stock on 09/29/2025 at a price of $89.50 per share under a previously established Rule 10b5-1 trading plan dated March 19, 2025. The Form 4 shows Mr. Sagara retains a direct beneficial ownership stake following the reported transaction and also holds an indirect interest of 2,404.47 shares through a 401(k) savings plan as of 09/26/2025. The filing was signed by an attorney-in-fact on Mr. Sagara's behalf and includes a Power of Attorney exhibit.

Positive

• Sale executed under a Rule 10b5-1(c) trading plan, reducing concerns about opportunistic insider timing
• Filing includes Exhibit 24 (Power of Attorney), indicating procedural formalities were followed
• Disclosure of indirect holdings in a 401(k) plan (2,404.47 shares) shows continued ownership alignment

Negative

• Director disposed of 14,433 shares at $89.50, a potentially material sale depending on the director's total holdings
• Post-transaction direct beneficial ownership figure is reported in a nonstandard numeric format in the filing, which could cause ambiguity for some readers

Insights

Financial Analyst

TL;DR: Director sold a meaningful block of SRE shares under a pre-set 10b5-1 plan; transaction is routine but increases share supply from insider.

The reported disposal of 14,433 shares at $89.50 under a March 19, 2025 Rule 10b5-1 plan indicates the sale was pre-authorized and not the result of contemporaneous, discretionary trading. For investors this reduces concerns about opportunistic timing by the director, though the size of the sale is notable relative to a typical director holding. The filing also discloses indirect holdings of 2,404.47 shares in a 401(k) plan, which provides some ongoing alignment with shareholder interests. No derivative transactions or additional material events are reported.

Corporate Governance Expert

TL;DR: Use of a Rule 10b5-1 plan and POA signature suggests governance controls were followed for the insider sale.

The Form 4 explicitly states the sale complied with a written instruction and a 10b5-1(c) plan, which is the accepted governance mechanism for scheduled insider trades and helps mitigate insider trading concerns. The signature by an attorney-in-fact and inclusion of Exhibit 24 (Power of Attorney) are consistent with procedural requirements for filings. There are no disclosures of accelerated option exercises, stock-based awards, or other governance actions in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Sagara Kevin C.

(Last) (First) (Middle)

488 8TH AVENUE

(Street)

SAN DIEGO CA 92101

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SEMPRA [ SRE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/29/2025		S(1)		14,433	D	$89.5	1,042.07	D
Common Stock								2,404.47	I	401(k) savings plan (9/26/2025)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares of common stock reflected in this Form 4 were sold in accordance with a written instruction and plan for trading securities established by Mr. Sagara on March 19, 2025 pursuant to Rule 10b5-1(c) under the Securities Exchange Act of 1934.

Remarks:

Exhibit 24 - Power of Attorney

	KEVIN C. SAGARA BY: Lisa H. Abbot, Managing Attorney - Corporate and Securities of Sempra and Attorney-In-Fact	09/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did SRE director Kevin C. Sagara report on his Form 4?

The Form 4 reports a sale of 14,433 shares of Sempra common stock on 09/29/2025 at $89.50 per share executed under a Rule 10b5-1 plan.

Was the sale by Kevin C. Sagara part of a pre-arranged trading plan?

Yes. The filing states the shares were sold pursuant to a written instruction and a 10b5-1(c) trading plan established on March 19, 2025.

Does the Form 4 disclose any indirect holdings for Kevin C. Sagara?

Yes. The filing discloses 2,404.47 shares held indirectly through a 401(k) savings plan as of 09/26/2025.

Was the Form 4 signed by Kevin C. Sagara?

The Form 4 was signed by an attorney-in-fact, Lisa H. Abbot, Managing Attorney - Corporate and Securities of Sempra, and includes Exhibit 24 (Power of Attorney).

Did the filing report any derivative transactions or option exercises?

No. Table II for derivative securities contains no reported transactions in this filing.